US6991907B1
(en)
*
|
1995-04-18 |
2006-01-31 |
Biosite, Inc. |
Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays
|
US6627404B1
(en)
*
|
1995-04-18 |
2003-09-30 |
Biosite, Inc. |
Methods for improving the recovery of troponin I and T in membranes, filters and vessels
|
DE19847690A1
(de)
*
|
1998-10-15 |
2000-04-20 |
Brahms Diagnostica Gmbh |
Verfahren und Substanzen für die Diagnose und Therapie von Sepsis und sepsisähnlichen systemischen Infektionen
|
AU2002218026A1
(en)
|
2000-11-09 |
2002-05-21 |
The Brigham And Women's Hospital, Inc. |
Cardiovascular disease diagnostic and therapeutic targets
|
US7635676B2
(en)
|
2001-02-21 |
2009-12-22 |
Alavita Pharmaccuticals, Inc. |
Modified annexin proteins and methods for their use in organ transplantation
|
US7645739B2
(en)
|
2001-02-21 |
2010-01-12 |
Alavita Pharmaceuticals, Inc. |
Modified annexin compositions and methods of using same
|
US7635680B2
(en)
|
2001-02-21 |
2009-12-22 |
Alavita Pharmaceuticals, Inc. |
Attenuation of reperfusion injury
|
US20040176914A1
(en)
*
|
2001-04-13 |
2004-09-09 |
Biosite Incorporated |
Methods and compositions for measuring biologically active natriuretic peptides and for improving their therapeutic potential
|
US20030219734A1
(en)
*
|
2001-04-13 |
2003-11-27 |
Biosite Incorporated |
Polypeptides related to natriuretic peptides and methods of their identification and use
|
US7632647B2
(en)
*
|
2001-04-13 |
2009-12-15 |
Biosite Incorporated |
Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
|
US20040253637A1
(en)
*
|
2001-04-13 |
2004-12-16 |
Biosite Incorporated |
Markers for differential diagnosis and methods of use thereof
|
US7713705B2
(en)
*
|
2002-12-24 |
2010-05-11 |
Biosite, Inc. |
Markers for differential diagnosis and methods of use thereof
|
US7524635B2
(en)
*
|
2003-04-17 |
2009-04-28 |
Biosite Incorporated |
Methods and compositions for measuring natriuretic peptides and uses thereof
|
US20030199000A1
(en)
*
|
2001-08-20 |
2003-10-23 |
Valkirs Gunars E. |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
JP2005522669A
(ja)
*
|
2001-08-20 |
2005-07-28 |
バイオサイト インコーポレイテッド |
卒中および脳損傷の診断マーカーおよびその使用方法
|
US7608406B2
(en)
|
2001-08-20 |
2009-10-27 |
Biosite, Inc. |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
US20040219509A1
(en)
*
|
2001-08-20 |
2004-11-04 |
Biosite, Inc. |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
US20040209307A1
(en)
*
|
2001-08-20 |
2004-10-21 |
Biosite Incorporated |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
US6461828B1
(en)
|
2001-09-04 |
2002-10-08 |
Syn X Pharma |
Conjunctive analysis of biological marker expression for diagnosing organ failure
|
HUE027779T2
(en)
|
2002-05-09 |
2016-11-28 |
Brigham & Womens Hospital Inc |
1L1RL-1 is a marker of cardiovascular disease
|
MXPA03004105A
(es)
*
|
2002-05-14 |
2004-10-15 |
Hoffmann La Roche |
Elaboracion de una prognosis en casos de enfermedad cardiaca usando una combinacion de marcadores.
|
JP5179011B2
(ja)
*
|
2002-10-09 |
2013-04-10 |
ディーエムアイ バイオサイエンシズ インコーポレイテッド |
胎盤虚血および多臓器不全のモニタリング
|
WO2004047871A2
(en)
*
|
2002-11-26 |
2004-06-10 |
Nobex Corporation |
Modified naturetic compounds, conjugates, and uses thereof
|
GB0229747D0
(en)
*
|
2002-12-20 |
2003-01-29 |
Axis Shield Asa |
Assay
|
JP2006526140A
(ja)
*
|
2002-12-24 |
2006-11-16 |
バイオサイト インコーポレイテッド |
鑑別診断のためのマーカーおよびその使用方法
|
CN102183656B
(zh)
*
|
2003-03-27 |
2014-04-16 |
儿童医院医疗中心 |
用于检测肾小管细胞损伤的早发的方法和试剂盒
|
DE10316583A1
(de)
|
2003-04-10 |
2004-10-28 |
B.R.A.H.M.S Aktiengesellschaft |
Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung
|
JP2006527190A
(ja)
*
|
2003-04-17 |
2006-11-30 |
サイファージェン バイオシステムズ インコーポレイテッド |
ナトリウム利尿ペプチドに関連したポリペプチド、並びにこれらの同定および使用法
|
WO2004097368A2
(en)
*
|
2003-04-28 |
2004-11-11 |
Ciphergen Biosystems, Inc. |
Improved immunoassays
|
WO2004105575A2
(en)
*
|
2003-05-29 |
2004-12-09 |
Trustee Of Darmouth College |
A method for detecting cardiac ischemia via changes in b-natriuretic peptide levels
|
WO2005033327A2
(en)
*
|
2003-09-29 |
2005-04-14 |
Biosite Incorporated |
Methods and compositions for the diagnosis of sepsis
|
US20050148029A1
(en)
*
|
2003-09-29 |
2005-07-07 |
Biosite, Inc. |
Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
|
DE10351238A1
(de)
*
|
2003-11-03 |
2005-06-02 |
Roche Diagnostics Gmbh |
Diagnosestellung von akuten myokardialen, ischämischen Erkrankungen durch Kombination von Markern
|
EP1530047A1
(de)
*
|
2003-11-07 |
2005-05-11 |
Roche Diagnostics GmbH |
Proximale Markermoleküle der Arterienthrombose und der Entzündung zur Risikostratifizierung einer koronaren Herzkrankheit
|
JP2007510935A
(ja)
*
|
2003-11-07 |
2007-04-26 |
プリンストン・バイオケミカルズ・インコーポレーテッド |
多次元電気泳動装置
|
US20050196817A1
(en)
*
|
2004-01-20 |
2005-09-08 |
Molecular Staging Inc. |
Biomarkers for sepsis
|
US20050181451A1
(en)
*
|
2004-02-12 |
2005-08-18 |
Bates Harold M. |
Detection of asymptomatic coronary artery disease using atherogenic proteins and acute phase reactants
|
US20080175191A1
(en)
*
|
2004-02-23 |
2008-07-24 |
Siemens Aktiengesellschaft |
Method, Intermediate Station and Central Control Unit For the Packet-Switched Data Transmission in a Self-Organizing Radio Network
|
US20050244892A1
(en)
*
|
2004-02-27 |
2005-11-03 |
Lazar Mitchell A |
Resistin as a marker and therapeutic target for cardiovascular disease
|
CA2563408C
(en)
*
|
2004-04-15 |
2015-08-25 |
Athera Biotechnologies Ab |
Annexin v for preventing atherothrombois and plaque rupture
|
US20050272101A1
(en)
*
|
2004-06-07 |
2005-12-08 |
Prasad Devarajan |
Method for the early detection of renal injury
|
DE102004028303A1
(de)
|
2004-06-11 |
2005-12-29 |
Roche Diagnostics Gmbh |
Verfahren und Vorrichtung zum Nachweis von Analyten
|
WO2005124364A1
(en)
|
2004-06-15 |
2005-12-29 |
F. Hoffmann-La Roche Ag |
The use of cardiac hormones for diagnosing the risk of suffering from a cardiovascular complication as a consequence of cardiotoxic medication
|
EP1615035B1
(de)
*
|
2004-07-07 |
2007-06-06 |
F.Hoffmann-La Roche Ag |
Kombinationen von Markern zum Nachweis von typ 1 und 2 Diabetes
|
AU2005318689B2
(en)
*
|
2004-12-20 |
2010-08-19 |
Antibodyshop A/S |
Determination of neutrophil gelatinase-associated lipocalin (NGAL) as a diagnostic marker for renal disorders
|
US20080050832A1
(en)
*
|
2004-12-23 |
2008-02-28 |
Buechler Kenneth F |
Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
|
US20080207505A1
(en)
*
|
2005-01-12 |
2008-08-28 |
James Kenneth D |
Bna Conjugates and Methods of Use
|
DK1849009T3
(da)
*
|
2005-01-24 |
2009-01-12 |
Hoffann La Roche Ag F |
Anvendelse af cardiachormoner til diagnose af cardiovaskulære risici som fölge af en administration af antiinflammatoriske lægemidler
|
EP1691200A1
(de)
*
|
2005-02-14 |
2006-08-16 |
F. Hoffmann-La Roche Ag |
Verwendung des BNP-Art und ANP-Art Peptiden für das Festsetzen der Gefahren von Herzgefäß- Komplikationen als Folge der Volumenüberlastung
|
US7432107B2
(en)
|
2005-01-24 |
2008-10-07 |
Roche Diagnostics Operations, Inc. |
Cardiac hormones for assessing cardiovascular risk
|
DE102005003687A1
(de)
*
|
2005-01-26 |
2006-07-27 |
Sphingo Tec Gmbh |
Immunoassay zur Bestimmung der Freisetzung von Neurotensin in die Zirkulation
|
US8900815B2
(en)
|
2005-02-21 |
2014-12-02 |
Saga University |
Platelet-derived microparticles as a novel diagnosis maker for a cardiovascular disease
|
CA2599731A1
(en)
*
|
2005-03-03 |
2006-09-08 |
Dmi Biosciences, Inc. |
Quantification of proteins
|
US20070037232A1
(en)
*
|
2005-03-31 |
2007-02-15 |
Barasch Jonathan M |
Detection of NGAL in chronic renal disease
|
US20060240444A1
(en)
*
|
2005-04-21 |
2006-10-26 |
Peiguo Chu |
Detection methods
|
US7300631B2
(en)
*
|
2005-05-02 |
2007-11-27 |
Bioscale, Inc. |
Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles
|
CN100422742C
(zh)
*
|
2005-05-16 |
2008-10-01 |
艾博(武汉)生物技术有限公司 |
急性心肌梗死早期诊断三合一检测试剂板
|
JP2008545139A
(ja)
*
|
2005-06-29 |
2008-12-11 |
ルールズ−ベースド メディスン,インコーポレーテッド |
急性冠症候群の診断方法及び診断キット
|
ES2288358B1
(es)
*
|
2005-07-01 |
2008-11-16 |
Proyecto De Biomedicina Cima, S.L. |
Marcadores de fibrosis.
|
JP4850001B2
(ja)
*
|
2005-09-05 |
2012-01-11 |
プリマハム株式会社 |
新規ストレスバイオマーカー及びその用途
|
AU2006299417A1
(en)
*
|
2005-10-03 |
2007-04-12 |
Biosite Incorporated |
Methods and compositions for diagnosis and/or prognosis in Systemic Inflammatory Response Syndromes
|
IL172297A
(en)
|
2005-10-03 |
2016-03-31 |
Compugen Ltd |
Soluble vegfr-1 variants for the diagnosis of preeclampsia
|
US20080090304A1
(en)
*
|
2006-10-13 |
2008-04-17 |
Barasch Jonathan Matthew |
Diagnosis and monitoring of chronic renal disease using ngal
|
US7399598B2
(en)
*
|
2005-10-14 |
2008-07-15 |
Taipei Medical University |
Diagnosis method of endometriosis by detecting biochemical markers and usage of these biochemical markers
|
US20110076255A1
(en)
*
|
2005-11-07 |
2011-03-31 |
Pecora Andrew L |
Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
|
JP2007131548A
(ja)
*
|
2005-11-08 |
2007-05-31 |
Hirosaki Univ |
プロテオグリカンの新規医薬用途
|
EP2431746A1
(de)
|
2005-11-17 |
2012-03-21 |
Biogen Idec MA Inc. |
Thrombozytenaggregationsprüfungen
|
US8906857B2
(en)
*
|
2005-12-01 |
2014-12-09 |
B.R.A.H.M.S. Gmbh |
Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
|
US9829494B2
(en)
*
|
2005-12-01 |
2017-11-28 |
Adrenomed Ag |
Methods of treatment using ADM antibodies
|
GB0601058D0
(en)
*
|
2006-01-19 |
2006-03-01 |
Univ Southampton |
Mast Cell Carboxypeptidase As A Marker For Anaphylaxis And Mastocytosis
|
US20070172888A1
(en)
*
|
2006-01-25 |
2007-07-26 |
Klaus Hallermayer |
Measuring troponin antibodies to assess cardiovascular risk
|
EP2005168A4
(de)
*
|
2006-03-09 |
2009-05-20 |
Biosite Inc |
Verfahren und zusammensetzung zur diagnose von krankheiten der aorta
|
ES2344993T3
(es)
*
|
2006-03-24 |
2010-09-13 |
F. Hoffmann-La Roche Ag |
Medios y metodos para la diferenciacion de la necrosis de miocardio aguda y cronica en pacientes sintomaticos.
|
AU2014200749B2
(en)
*
|
2006-04-04 |
2016-04-14 |
Singulex, Inc. |
Highly sensitive system and methods for analysis of troponin
|
JP5308328B2
(ja)
*
|
2006-04-04 |
2013-10-09 |
シングレックス,インコーポレイテッド |
トロポニンの分析のための高感度のシステムおよび方法
|
US7838250B1
(en)
|
2006-04-04 |
2010-11-23 |
Singulex, Inc. |
Highly sensitive system and methods for analysis of troponin
|
JP6325022B2
(ja)
*
|
2006-04-04 |
2018-05-16 |
シングレックス,インコーポレイテッド |
トロポニンの分析のための高感度のシステムおよび方法
|
EP1845379A1
(de)
|
2006-04-13 |
2007-10-17 |
F. Hoffmann-La Roche AG |
Mittel und Verfahren zur Differenzierung kardialer und pulmonaler Ursachen von Atemnot
|
CA2650201C
(en)
|
2006-04-24 |
2020-10-20 |
James V. Snider |
Predicting mortality and detecting severe disease
|
EP2010921B1
(de)
*
|
2006-04-24 |
2010-07-07 |
Medizinische Universität Wien |
Verfahren zur diagnose von herz-kreislauf-krankheiten
|
EP3059594A1
(de)
*
|
2006-05-01 |
2016-08-24 |
Critical Care Diagnostics, Inc. |
Prognose von herz-kreislauf-erkrankung
|
PL2019965T3
(pl)
*
|
2006-05-02 |
2015-10-30 |
Critical Care Diagnostics Inc |
Rozpoznawanie różnicowe chorób układu oddechowego i sercowo-naczyniowego
|
US20080118924A1
(en)
*
|
2006-05-26 |
2008-05-22 |
Buechler Kenneth F |
Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases
|
PL2035835T3
(pl)
|
2006-05-30 |
2012-05-31 |
Antibodyshop As |
Sposoby szybkiej oceny ciężkości urazu
|
US7935498B2
(en)
*
|
2006-07-07 |
2011-05-03 |
Siemens Healthcare Diagnostics Inc. |
Methods for identifying patients with increased risk of an adverse cardiovascular event
|
EP1882945A1
(de)
|
2006-07-28 |
2008-01-30 |
F.Hoffmann-La Roche Ag |
Vorrichtungen und Verfahren zur Differentierung zwischen herz- und lungenbedingten Ursachen für akute Atemnot
|
CA2660691C
(en)
|
2006-08-04 |
2020-01-14 |
Medizinische Hochschule Hannover |
Means and methods for assessing the risk of cardiac interventions based on gdf-15
|
WO2008017306A1
(en)
*
|
2006-08-07 |
2008-02-14 |
Antibodyshop A/S |
Diagnostic test to exclude significant renal injury
|
EP1890153A1
(de)
|
2006-08-16 |
2008-02-20 |
F. Hoffman-la Roche AG |
Herztroponin als Indikator für fortgeschrittene Koronararterienerkrankung
|
US20080050749A1
(en)
*
|
2006-08-17 |
2008-02-28 |
Ildiko Amann-Zalan |
Use of bnp-type peptides for the stratification of therapy with erythropoietic stimulating agents
|
US8158374B1
(en)
|
2006-09-05 |
2012-04-17 |
Ridge Diagnostics, Inc. |
Quantitative diagnostic methods using multiple parameters
|
ATE449966T1
(de)
|
2006-09-15 |
2009-12-15 |
Hoffmann La Roche |
Biochemische marker für akute lungenembolie
|
EP1901073A1
(de)
|
2006-09-18 |
2008-03-19 |
Roche Diagnostics GmbH |
Natriuretische Peptide zur Diagnose von Herzkomplikationen infolge von Koronarkatheterisierung
|
ATE476665T1
(de)
*
|
2006-09-20 |
2010-08-15 |
Hoffmann La Roche |
Natriurethische peptide und plazenta- wachstumfaktor/löslicher vegf-rezeptor unterscheiden zwischen mit der plazenta verbundener herzdysfunktion und mit herzerkrankung verbundener herzdysfunktion
|
WO2008049422A2
(de)
|
2006-10-26 |
2008-05-02 |
Brahms Aktiengesellschaft |
Risikostratifizierung des akuten koronarsyndroms mittels fragmenten / teilpeptiden des provasopressins, insbesondere copeptin oder neurophysin ii
|
EP2095106B1
(de)
*
|
2006-11-14 |
2013-03-20 |
Alere San Diego, Inc. |
Verfahren und zusammensetzungen zur diagnose und prognose von nierenarterienstenose
|
EP2095107B1
(de)
|
2006-11-14 |
2014-07-02 |
Alere San Diego, Inc. |
Verfahren zur risikoabschätzung
|
EP1925943A1
(de)
|
2006-11-21 |
2008-05-28 |
F. Hoffman-la Roche AG |
Vorrichtungen und Verfahren zur Optimierung von diagnostischen and therapeutischen Ansätzen für chronische Arterienerkrankungen basierend auf dem Nachweis von Troponin T und NT-proBNP.
|
JP5240945B2
(ja)
*
|
2006-11-28 |
2013-07-17 |
ピクター リミテッド |
アッセイ膜およびその使用法
|
CN106908603B
(zh)
*
|
2007-01-25 |
2019-04-02 |
霍夫曼-拉罗奇有限公司 |
Igfbp-7在心力衰竭评估中的用途
|
NZ578077A
(en)
|
2007-02-12 |
2012-04-27 |
Stefan Hansson |
Diagnosis of preeclampsia using free foetal haemoglobin
|
WO2008107201A1
(en)
*
|
2007-03-08 |
2008-09-12 |
Roche Diagnostics Gmbh |
Use of slim-1 in the assessment of heart failure
|
GB0705223D0
(en)
*
|
2007-03-19 |
2007-04-25 |
Univ Sussex |
Method, apparatus and computer program for analysing medical image data
|
CN101680903A
(zh)
*
|
2007-03-21 |
2010-03-24 |
比奥波托诊断股份公司 |
肾损伤的诊断试验
|
US8221995B2
(en)
|
2007-03-23 |
2012-07-17 |
Seok-Won Lee |
Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
|
US20090004755A1
(en)
*
|
2007-03-23 |
2009-01-01 |
Biosite, Incorporated |
Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
|
EP2145185A4
(de)
|
2007-04-30 |
2010-06-02 |
Nanogen Inc |
Multianalyt-assay
|
DE102007022367A1
(de)
*
|
2007-05-07 |
2008-11-20 |
B.R.A.H.M.S Ag |
Verfahren zur Bestimmung von aminoterminalen pro-ANP bei übergewichtigen Patienten
|
US20080280377A1
(en)
*
|
2007-05-08 |
2008-11-13 |
Abbott Laboratories |
Human b-type natriuretic peptide assay having reduced cross-reactivity with other peptide forms
|
EP1998178A1
(de)
*
|
2007-05-29 |
2008-12-03 |
F. Hoffman-la Roche AG |
H-FABP als Prädiktor für Herzinfarkt
|
WO2009000784A1
(de)
*
|
2007-06-22 |
2008-12-31 |
Brahms Aktiengesellschaft |
Verfahren zur detektion von analyten
|
ES2377112T3
(es)
|
2007-08-03 |
2012-03-22 |
B.R.A.H.M.S Gmbh |
Método para el diagnóstico de una infección bacteriana
|
EP2031397A1
(de)
|
2007-08-30 |
2009-03-04 |
F. Hoffmann-La Roche AG |
Surfactantproteine B und D bei der Unterscheidung der Ursachen für Atemnot
|
JP2011501113A
(ja)
|
2007-10-10 |
2011-01-06 |
エフ.ホフマン−ラ ロシュ アーゲー |
急性冠症候群を有する患者での既存の心筋機能不全の評価のためのナトリウム利尿ペプチド/トロポニン比
|
EP2538221A3
(de)
*
|
2007-11-05 |
2013-04-24 |
Nordic Bioscience A/S |
Biochemische Marker zur Bewertung des CVD-Risikos
|
JP2011503587A
(ja)
*
|
2007-11-15 |
2011-01-27 |
バイオポルト ディアグノスティックス エイ/エス |
独特の分子形態を有するタンパク質バイオマーカーの診断における使用
|
JP2011506614A
(ja)
|
2007-12-17 |
2011-03-03 |
ダイアックス コーポレーション |
Mmp−14結合タンパク質を含む、骨溶解性障害を処置するための組成物および方法
|
WO2009111508A2
(en)
|
2008-03-03 |
2009-09-11 |
Dyax Corp. |
Metalloproteinase 9 and metalloproteinase 2 binding proteins
|
CA2717576A1
(en)
|
2008-03-03 |
2009-09-11 |
Dyax Corp. |
Metalloproteinase 9 binding proteins
|
US20100100333A1
(en)
*
|
2008-10-15 |
2010-04-22 |
Ridge Diagnostics, Inc. |
Human biomarker hypermapping for depressive disorders
|
US7927880B2
(en)
|
2008-05-21 |
2011-04-19 |
Mohan Rajapurkar |
Methods and kit for early detection of acute coronary syndrome and prediction of adverse cardiac events
|
CN102016552A
(zh)
*
|
2008-03-05 |
2011-04-13 |
神谷来克斯公司 |
用于分子的高灵敏性检测的方法和组合物
|
ES2420841T3
(es)
*
|
2008-03-05 |
2013-08-27 |
Mohan Rajapurkar |
Procedimientos para la detección precoz del síndrome coronario agudo y predicción de acontecimientos cardiacos adversos
|
EP2103943A1
(de)
|
2008-03-20 |
2009-09-23 |
F. Hoffman-la Roche AG |
GDF-15 zur Beurteilung eines kardiovaskulären Risikos hinsichtlich Verabreichung von Entzündungshemmern
|
PT3093663T
(pt)
|
2008-04-18 |
2018-10-19 |
Critical Care Diagnostics Inc |
Previsão do risco de eventos cardíacos adversos maiores
|
EP2294424A1
(de)
|
2008-05-21 |
2011-03-16 |
F. Hoffmann-La Roche AG |
L-fabp, natriuretische peptide und herztroponin bei individuen, die eine herztherapie benötigen
|
US8497078B2
(en)
|
2008-05-23 |
2013-07-30 |
The Johns Hopkins University |
Biomarkers for myocardial ischemia
|
EP2133696A1
(de)
|
2008-06-10 |
2009-12-16 |
Eberhardt Spanuth |
Sehr geringe Konzentrationen von Troponin I oder T zur Beurteilung eines kardiovaskulären Risikos hinsichtlich der Verabreichung von Entzündungshemmern
|
EP2304438A1
(de)
*
|
2008-06-13 |
2011-04-06 |
F. Hoffmann-La Roche AG |
Beurteilung von komplikationen bei patienten mit typ-1-diabetes
|
EP2148203A1
(de)
*
|
2008-07-23 |
2010-01-27 |
BRAHMS Aktiengesellschaft |
Azurophili-Granulat-Proteasen als Marker bei Herzkrankheiten
|
EP2324358A1
(de)
*
|
2008-07-23 |
2011-05-25 |
F. Hoffmann-La Roche AG |
Überwachung einer antiangiogenesetherapie
|
EP2321651B1
(de)
|
2008-07-23 |
2017-08-23 |
F. Hoffmann-La Roche AG |
Identifikation von für eine anti-angiogenese-therapie geeigneten personen
|
EP2331964A1
(de)
|
2008-08-13 |
2011-06-15 |
Roche Diagnostics GmbH |
D-dimer, troponin, nt-probnp bei lungenembolie
|
US9366680B2
(en)
*
|
2008-08-28 |
2016-06-14 |
Shimadzu Corporation |
Method for evaluating myocardial ischemic state using blood sample
|
US20120083421A1
(en)
*
|
2008-10-16 |
2012-04-05 |
The Trustees Of Columbia University In The City Of New York |
Use of urinary ngal to diagnose and monitor hiv-associated nephropathy (hivan)
|
US20100159474A1
(en)
*
|
2008-11-11 |
2010-06-24 |
B.R.A.H.M.S. Aktiengesellschaft |
Prognosis and risk assessment in patients suffering from heart failure by determining the level of adm and bnp
|
CN102301234B
(zh)
*
|
2008-11-18 |
2015-06-17 |
里奇诊断学股份有限公司 |
针对重度抑郁疾病的代谢综合症状及hpa轴生物标志物
|
US8457724B2
(en)
*
|
2008-12-11 |
2013-06-04 |
Siemens Medical Solutions Usa, Inc. |
System for heart performance characterization and abnormality detection
|
CN102341705B
(zh)
*
|
2009-03-05 |
2015-08-19 |
味之素株式会社 |
克罗恩氏病诊断试剂
|
HUE043684T2
(hu)
*
|
2009-03-11 |
2019-09-30 |
Augurex Life Sciences Corp |
Arthritikus állapotok jellemzésére szolgáló készítmények és eljárások
|
CN102460153A
(zh)
*
|
2009-04-06 |
2012-05-16 |
里奇诊断学股份有限公司 |
监控神经精神疾病治疗的生物标记
|
CN104087662A
(zh)
|
2009-04-29 |
2014-10-08 |
阿姆斯特丹大学学术医学中心 |
对抗、预防和/或测定心力衰竭或心力衰竭的风险的工具和方法
|
EP2435079A4
(de)
*
|
2009-05-26 |
2012-11-14 |
Univ Johns Hopkins |
Neue desminphosphorylierungsorte zur diagnostizierung und beeinflussung von herzerkrankungen
|
JP5678045B2
(ja)
|
2009-06-08 |
2015-02-25 |
シンギュレックス・インコーポレイテッド |
高感度バイオマーカーパネル
|
US20120164662A1
(en)
*
|
2009-06-10 |
2012-06-28 |
HARA Masanori |
Test method on renal diseases
|
US8889625B2
(en)
*
|
2009-07-10 |
2014-11-18 |
Northwestern University |
Cardioprotective role of hepatic cells and hepatocyte secretory factors in myocardial ischemia
|
RU2548710C2
(ru)
|
2009-09-17 |
2015-04-20 |
Ф.Хоффманн-Ля Рош Аг |
Мультимаркерная панель для гипертрофии левого желудочка
|
CN102782498A
(zh)
|
2009-10-21 |
2012-11-14 |
斯克里普斯研究所 |
用非稀有细胞检测稀有细胞的方法
|
WO2011057251A2
(en)
|
2009-11-09 |
2011-05-12 |
The Brigham And Women's Hospital, Inc. |
Treatment of heart disease
|
US20120321595A1
(en)
|
2009-11-09 |
2012-12-20 |
The Brigham And Women's Hospital, Inc. |
Treatment of heart disease
|
WO2011060361A1
(en)
*
|
2009-11-13 |
2011-05-19 |
Bg Medicine, Inc. |
Risk factors and prediction of myocardial infarction
|
ES2536712T3
(es)
*
|
2009-11-27 |
2015-05-27 |
Baker Idi Heart And Diabetes Institute Holdings Ltd |
Biomarcadores lipidómicos para la enfermedad cardiaca estable e inestable
|
EP3246708A3
(de)
|
2009-12-18 |
2018-01-03 |
Roche Diagnostics GmbH |
Troponins zur prognose von nierenausfall bei herzchirurgiepatienten
|
WO2011094308A2
(en)
*
|
2010-01-26 |
2011-08-04 |
Ridge Diagnostics, Inc. |
Multiple biomarker panels to stratify disease severity and monitor treatment of depression
|
WO2011098519A1
(en)
|
2010-02-12 |
2011-08-18 |
Synlab Medizinisches Versorgungszentrum Heidelberg Gmbh |
Homoarginine as a biomarker for the risk of mortality
|
MX2012011007A
(es)
*
|
2010-03-24 |
2013-03-20 |
Preelumina Diagnostics Ab |
Hemoglobina fetal (hbf) y alfa 1-microglobulina (a1m) como marcadores de etapa temprana para preeclampsia.
|
JP2013525820A
(ja)
|
2010-05-06 |
2013-06-20 |
シングレクス、インコーポレイテッド |
関節リウマチの発症に関するリスクを診断し、病期分類し、予測し、治療レスポンダーを同定するための方法
|
EP2388594A1
(de)
|
2010-05-17 |
2011-11-23 |
Roche Diagnostics GmbH |
Mittel auf GDF-15-Basis sowie Verfahren zur Überlebens- und Genesungsvorhersage bei akuter Entzündung
|
JP2013529907A
(ja)
|
2010-05-24 |
2013-07-25 |
ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク |
Ngalタンパク質変異体及びその使用
|
WO2011153127A1
(en)
|
2010-06-01 |
2011-12-08 |
Cardiac Pacemakers, Inc. |
Integrating sensors and biomarker assays to detect worsening heart failure
|
CN101942416B
(zh)
*
|
2010-07-23 |
2012-03-28 |
中国医学科学院放射医学研究所 |
抗人心肌肌钙蛋白i特异性单克隆抗体及其制备方法
|
US11739366B2
(en)
*
|
2010-07-23 |
2023-08-29 |
Astellas Institute For Regenerative Medicine |
Methods for detection of rare subpopulations of cells and highly purified compositions of cells
|
WO2012018535A2
(en)
*
|
2010-07-26 |
2012-02-09 |
Wellness Indicators, Inc. |
Wellness panel
|
WO2012020045A1
(en)
|
2010-08-10 |
2012-02-16 |
Roche Diagnostics Gmbh |
Method for selecting patients with stable coronary artery disease for pci or medical treatment
|
US8956859B1
(en)
|
2010-08-13 |
2015-02-17 |
Aviex Technologies Llc |
Compositions and methods for determining successful immunization by one or more vaccines
|
EP2367006A1
(de)
|
2010-08-24 |
2011-09-21 |
Roche Diagnostics GmbH |
Mittel und Verfahren auf PLGF-Basis zur Diagnose kardialer Ursachen bei akuten Entzündungen
|
CN105044349B
(zh)
|
2010-08-26 |
2018-04-06 |
弗·哈夫曼-拉罗切有限公司 |
生物标志物在评估从动脉高血压向心力衰竭的早期转变中的用途
|
EP2439535A1
(de)
|
2010-10-07 |
2012-04-11 |
F. Hoffmann-La Roche AG |
Diagnose von Herzerkrankungen im Zusammenhang mit Diabetes und GDF-15 und Troponin als Prädiktor für die Entwicklung von Diabetes mellitus Typ 2
|
EP2447720A1
(de)
|
2010-10-26 |
2012-05-02 |
Roche Diagnostics GmbH |
sFlt1 und Lungenkomplikationen
|
US8868168B2
(en)
|
2010-11-11 |
2014-10-21 |
Siemens Medical Solutions Usa, Inc. |
System for cardiac condition characterization using electrophysiological signal data
|
US8818494B2
(en)
|
2010-11-29 |
2014-08-26 |
Siemens Medical Solutions Usa, Inc. |
System for ventricular function abnormality detection and characterization
|
EP2383579A1
(de)
|
2010-12-17 |
2011-11-02 |
F. Hoffmann-La Roche AG |
sFlt-1, Kardiotroponine und natriuretische Peptide beim Nachweis einer Therapie mit HER-2-Inhibitoren
|
BR112013018696A2
(pt)
*
|
2011-01-20 |
2016-10-18 |
Immunosciences Lab Inc |
métodos e aparelhos para detectar sensitividade ao glúten e sua difrenciação da doença celiática
|
GB2490652A
(en)
*
|
2011-04-18 |
2012-11-14 |
Microtest Matrices Ltd |
Methods of quantifying antibodies, especially IgE antibodies in a sample
|
US8754044B2
(en)
|
2011-05-03 |
2014-06-17 |
Northwestern University |
Neuroprotection by hepatic cells and hepatocyte secretory factors
|
US8684942B2
(en)
|
2011-05-25 |
2014-04-01 |
Siemens Medical Solutions Usa, Inc. |
System for cardiac impairment detection based on signal regularity
|
EP2385373A1
(de)
|
2011-07-01 |
2011-11-09 |
F. Hoffmann-La Roche AG |
Natriuretische Peptide bei der Schwangerschaft
|
US20120258477A1
(en)
*
|
2011-07-25 |
2012-10-11 |
Northwestern University |
Fecal neopterin concentration measurement as an indicator of disease activity in inflammatory bowel disease
|
EP2581040A1
(de)
|
2011-10-10 |
2013-04-17 |
Roche Diagnostics GmbH |
TNT-basiertes Herzhypertrophierisiko im Zusammenhang mit physiologischem Training und Führung in Athleten
|
EP2769227B1
(de)
|
2011-10-17 |
2016-07-27 |
Roche Diagnostics GmbH |
Auf troponin und bnp basierende diagnose von risikopatienten und ursache eines schlaganfalls
|
WO2013059439A2
(en)
|
2011-10-21 |
2013-04-25 |
Dyax Corp. |
Combination therapy comprising an mmp-14 binding protein
|
PT2780369T
(pt)
|
2011-11-16 |
2019-06-18 |
Adrenomed Ag |
Anticorpo antiadrenomedulina (adm) ou fragmento de anticorpo anti-adm ou uma estrutura não ig anti-adm, para a prevenção ou a redução de disfunções de órgãos ou de insuficiências de órgãos num doente com uma doença aguda ou crónica ou com uma patologia aguda
|
PT2780370T
(pt)
|
2011-11-16 |
2019-10-30 |
Adrenomed Ag |
Anticorpo anti-adrenomedulina (adm) ou fragmento anticorpo anti-adm ou estrutura de anticorpo anti-adm não ig para utilização na terapia de uma doença aguda ou condição aguda de um paciente para estabilizar a circulação
|
WO2013072509A1
(en)
|
2011-11-16 |
2013-05-23 |
Adrenomed Ag |
Adrenomedullin assays and methods for determining mature adrenomedullin
|
DK2780371T3
(en)
|
2011-11-16 |
2019-02-25 |
Adrenomed Ag |
ANTI-ADDRENOMEDULLIN (ADM) ANTIBODY OR ANTI-ADM ANTISTOFFRAGMENT OR ANTI-ADM NON-IG TEMPLATE FOR REGULATING LIQUID BALANCE OF A PATIENT WITH A CHRONIC OR ACUTE DISEASE
|
JP6059735B2
(ja)
|
2011-12-01 |
2017-01-11 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
脳卒中診断のためのNT−proANP及びNT−proBNP
|
CN103163295B
(zh)
*
|
2011-12-08 |
2015-11-18 |
吴宗贵 |
一种用于急性冠脉综合征的液相芯片试剂盒以其制备方法
|
CN104136924B
(zh)
*
|
2011-12-15 |
2018-05-29 |
麦卡蒂斯股份有限公司 |
用于先兆子痫的生物标志物和参数
|
JP5814800B2
(ja)
*
|
2011-12-28 |
2015-11-17 |
株式会社Lsiメディエンス |
神経変性疾患の検出方法
|
ES2538226T3
(es)
|
2012-01-26 |
2015-06-18 |
F. Hoffmann-La Roche Ag |
Método para la diferenciación de la insuficiencia cardiaca anterógrada y retrógrada
|
WO2013116544A1
(en)
|
2012-01-31 |
2013-08-08 |
Cardiac Pacemakers, Inc. |
Systems and methods for controlling a cardiac resynchronisation device/therapy using biomarker panel data
|
JP5951804B2
(ja)
*
|
2012-01-31 |
2016-07-13 |
カーディアック ペースメイカーズ, インコーポレイテッド |
移植可能な医療装置及びバイオマーカーパネルデータをcrt後のlvesv低減のリスクの指標とするための方法
|
EP2650684A1
(de)
|
2012-04-10 |
2013-10-16 |
Roche Diagniostics GmbH |
Diagnose auf Pro-SP-B und NT-proBNP bei Patienten mit Lungenentzündung
|
US8903480B2
(en)
|
2012-04-11 |
2014-12-02 |
Siemens Medical Solutions Usa, Inc. |
System for cardiac condition detection using heart waveform area associated analysis
|
WO2013163269A1
(en)
*
|
2012-04-24 |
2013-10-31 |
Sri International |
Human serum biomarkers of prostate cancer and sars-cov
|
EP2615459A1
(de)
|
2012-04-27 |
2013-07-17 |
Roche Diagniostics GmbH |
Verfahren zur Diagnose von Distalbronchoalveolargewebeschäden in Asthma durch Erkennen von proSP-B
|
US20150141278A1
(en)
*
|
2012-05-30 |
2015-05-21 |
Clarient Diagnostic Services, Inc. |
Multiplexed assay method for lung cancer classification
|
WO2013183725A1
(ja)
*
|
2012-06-06 |
2013-12-12 |
国立大学法人九州大学 |
非ヒトモデル動物、非ヒトモデル動物の作製方法及び抗血栓薬のスクリーニング方法
|
EP2600155A1
(de)
|
2012-06-18 |
2013-06-05 |
Roche Diagniostics GmbH |
sFlt-1-basierte Diagnose und Überwachung von Schlaganfallpatienten
|
EP2597467A1
(de)
|
2012-06-26 |
2013-05-29 |
Roche Diagniostics GmbH |
Mittel und Verfahren zur proSP-B-basierten Diagnose von Lungenstauung bei Patienten mit akutem Koronarsyndrom
|
EP2597466A1
(de)
|
2012-06-26 |
2013-05-29 |
Roche Diagniostics GmbH |
Mittel und Verfahren zur proSP-B-basierten Diagnose von Alveolenbeschädigung bei Patienten mit pulmonaler Hypertonie
|
WO2014009418A1
(en)
|
2012-07-10 |
2014-01-16 |
Roche Diagnostics Gmbh |
TnT, NTproBNP, sFlt-1 for CURB65 IN PNEUMONIA
|
WO2014031764A1
(en)
|
2012-08-21 |
2014-02-27 |
Critical Care Diagnostics, Inc. |
Multimarker risk stratification
|
CA2883890C
(en)
|
2012-09-12 |
2021-11-09 |
Dirk Block |
Identification of patients with abnormal fractional shortening
|
WO2014053502A1
(en)
*
|
2012-10-02 |
2014-04-10 |
Sphingotec Gmbh |
A method for predicting the risk of getting cancer or diagnosing cancer in a female subject
|
US20140273273A1
(en)
|
2012-11-01 |
2014-09-18 |
Christie Mitchell Ballantyne |
Biomarkers to improve prediction of heart failure risk
|
EP2917736B1
(de)
|
2012-11-09 |
2019-12-25 |
Roche Diagnostics GmbH |
Tnt- oder bnp-basierte diagnose von paroxysmalem vorhofflimmern
|
EP2730923A1
(de)
|
2012-11-09 |
2014-05-14 |
Roche Diagniostics GmbH |
NTproBNP- und cTnT-basierte Therapieanleitung bei Herzversagen
|
WO2014081980A2
(en)
|
2012-11-21 |
2014-05-30 |
The Trustees Of Columbia University In The City Of New York |
Mutant ngal proteins and uses thereof
|
EP3399315A3
(de)
|
2012-12-04 |
2019-01-02 |
Roche Diagnostics GmbH |
Biomarker zur auswahl einer therapie von herzversagen
|
DE102012223378A1
(de)
*
|
2012-12-17 |
2014-06-18 |
Charité - Universitätsmedizin Berlin |
In-vitro Verfahren und Kit zur Diagnose von akutem Koronarsyndrom
|
US20160195535A1
(en)
*
|
2012-12-20 |
2016-07-07 |
National University Corporation Hokkaido University |
Method for detecting prostatic basal cells
|
US20160116472A1
(en)
*
|
2013-02-04 |
2016-04-28 |
The General Hospital Corporation |
Biomarkers for stroke diagnosis
|
KR101494882B1
(ko)
*
|
2013-02-21 |
2015-02-25 |
한국과학기술연구원 |
급성 심근 경색 진단용 조성물, 그 조성물을 포함하는 급성 심근 경색 진단용 키트 및 급성 심근 경색 진단 방법
|
US9020583B2
(en)
|
2013-03-13 |
2015-04-28 |
Siemens Medical Solutions Usa, Inc. |
Patient signal analysis and characterization
|
EP2866033A1
(de)
|
2013-10-23 |
2015-04-29 |
Roche Diagniostics GmbH |
Differenzialdiagnose von akuter Atemnot auf Basis von c-terminiertem proSP-B, KL-6 und BNP-Peptiden
|
WO2015066035A1
(en)
*
|
2013-10-28 |
2015-05-07 |
The Forsyth Institute |
Compositions and methods for evaluating metabolic syndrome and related diseases
|
CA2929444C
(en)
|
2013-11-04 |
2023-12-19 |
F. Hoffmann-La Roche Ag |
Biomarkers and methods for progression prediction for chronic kidney disease
|
EP3069146A4
(de)
*
|
2013-11-15 |
2017-04-05 |
Otago Innovation Limited |
Biomarker für herzerkrankungen
|
WO2015112960A1
(en)
*
|
2014-01-27 |
2015-07-30 |
Epic Sciences, Inc. |
Circulating tumor cell diagnostics for detection of neuroendocrine prostate cancer (nepc)
|
EP3470848A3
(de)
|
2014-01-28 |
2019-05-22 |
Roche Diagnostics GmbH |
Biomarker zur risikobewertung und behandlungsüberwachung bei patienten mit herzinsuffizienz durch natriuretische peptide
|
EA201691682A1
(ru)
|
2014-02-21 |
2017-02-28 |
Эпик Сайенсиз, Инк. |
Способы анализирования редких циркулирующих в крови клеток
|
EP2916134B1
(de)
|
2014-03-05 |
2017-08-16 |
Roche Diagnostics GmbH |
Verwendung von Seprase zur Differenzialdiagnose von akuter Atemnot
|
ES2676553T3
(es)
|
2014-03-26 |
2018-07-20 |
F. Hoffmann-La Roche Ag |
IGFBP7 para el diagnóstico de la disfunción diastólica
|
JP2017530356A
(ja)
|
2014-09-26 |
2017-10-12 |
ソマロジック, インコーポレイテッドSomaLogic, Inc. |
心血管系のリスクイベントの予測及びその使用
|
SG11201705444QA
(en)
*
|
2015-01-09 |
2017-07-28 |
Global Genomics Group Llc |
Blood based biomarkers for diagnosing atherosclerotic coronary artery disease
|
WO2017134264A1
(en)
|
2016-02-04 |
2017-08-10 |
Metanomics Gmbh |
Means and methods for differentiating between heart failure and pulmonary disease in a subject
|
AU2017246588A1
(en)
*
|
2016-04-08 |
2018-09-27 |
Centre National De La Recherche Scientifique - Cnrs - |
Methods and kits for diagnosing postoperative pulmonary infections in patients who underwent surgery
|
EP3279665B1
(de)
|
2016-08-04 |
2020-07-08 |
Roche Diagniostics GmbH |
Zirkulierende esm-1 (endocan) bei der beurteilung von vorhofflimmern
|
WO2018069487A1
(en)
|
2016-10-14 |
2018-04-19 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and kits for predicting the risk of loss of renal function in patients with type 2 diabetes
|
WO2018127372A1
(en)
|
2016-12-13 |
2018-07-12 |
Witteman Johanna Cornelia Maria |
Detection of transient troponin peaks for diagnosis of subjects at high risk of cardiovascular disease
|
EP3360570A1
(de)
|
2017-02-13 |
2018-08-15 |
Roche Diagnostics GmbH |
Monoklonale antikörper für nt-probnp punktmutationen
|
CN112204397A
(zh)
*
|
2018-03-30 |
2021-01-08 |
荣研化学株式会社 |
新型主动脉瘤标志物
|
EP3572813A1
(de)
*
|
2018-05-22 |
2019-11-27 |
Centre National de la Recherche Scientifique |
Diagnoseverfahren von multipler sklerose
|
IT201800007264A1
(it)
*
|
2018-07-17 |
2020-01-17 |
|
Metodo per la diagnosi in vitro di carcinoma della prostata mediante biomarcatori urinari
|
BR112021001798A2
(pt)
|
2018-07-31 |
2021-04-27 |
F. Hoffmann-La Roche Ag |
métodos para avaliar a fibrilação atrial, para diagnosticar insuficiência cardíaca, para auxiliar na avaliação da fibrilação atrial, para prever o risco de acidente vascular cerebral e para aprimorar a precisão da previsão, usos e kit
|
KR20210044216A
(ko)
|
2018-08-10 |
2021-04-22 |
에프. 호프만-라 로슈 아게 |
심방세동-관련 뇌졸중 평가를 위한 ces-2 (카르복실에스테라제-2)
|
CN113302497A
(zh)
|
2018-08-16 |
2021-08-24 |
豪夫迈·罗氏有限公司 |
循环tfpi-2(组织因子途径抑制剂2)在心房颤动和抗凝治疗评定中的应用
|
KR20210044257A
(ko)
|
2018-08-17 |
2021-04-22 |
에프. 호프만-라 로슈 아게 |
심방 세동의 평가에서의 순환 bmp10 (골형성 단백질 10)
|
CN113302498A
(zh)
|
2018-08-22 |
2021-08-24 |
豪夫迈·罗氏有限公司 |
循环spon-1(脊椎蛋白-1)在心房颤动评定中的应用
|
JP7451499B2
(ja)
|
2018-08-24 |
2024-03-18 |
エフ. ホフマン-ラ ロシュ アーゲー |
心房細動の判定および脳卒中の予測のための循環fgfbp-1(線維芽細胞成長因子結合タンパク質1)
|
WO2020064995A1
(en)
|
2018-09-28 |
2020-04-02 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of biomarkers representing cardiac, vascular and inflammatory pathways for the prediction of acute kidney injury in patients with type 2 diabetes
|
CN111192687A
(zh)
*
|
2018-11-14 |
2020-05-22 |
复旦大学附属儿科医院 |
一种进展期阑尾炎列线图预测模型及其用途
|
US20220229075A1
(en)
|
2019-05-23 |
2022-07-21 |
Roche Diagnostics Operations, Inc. |
IGFBP7 RATIO FOR HFpEF
|
WO2021026362A1
(en)
*
|
2019-08-07 |
2021-02-11 |
Edifice Health, Inc. |
Treatment of prevention of cardiovascular disease
|
EP4107182A1
(de)
|
2020-02-20 |
2022-12-28 |
Universiteit Maastricht |
Nachweisverfahren für zirkulierendes bmp10 (knochenmorphogenetisches protein 10)
|
US20220163528A1
(en)
|
2020-07-29 |
2022-05-26 |
Pictor Limited |
IMMUNOASSAY FOR SARS-CoV-2 ANTIBODIES
|
WO2022069658A1
(en)
|
2020-09-30 |
2022-04-07 |
F. Hoffmann-La Roche Ag |
Circulating total-nt-probnp (glycosylated and unglycosylated nt-probnp) and its ratio with nt-probnp (unglycosylated nt-probnp) in the assessment of atrial fibrillation
|
CN114182010B
(zh)
*
|
2022-01-11 |
2022-06-07 |
首都医科大学附属北京朝阳医院 |
一种血浆外泌体circRNA标志物及其应用
|
WO2023175176A1
(en)
|
2022-03-18 |
2023-09-21 |
Roche Diagnostics Gmbh |
Cmybpc marker combinations for early discrimination of type 2 versus type 1 acute myocardial infarction
|
WO2023175152A1
(en)
|
2022-03-18 |
2023-09-21 |
Roche Diagnostics Gmbh |
Troponin marker combinations for early discrimination of type 2 versus type 1 acute myocardial infarction
|
WO2024100050A1
(en)
|
2022-11-07 |
2024-05-16 |
Hôpitaux Universitaires Saint-Louis-Lariboisière |
Rapid optimization of oral heart failure therapies helped by nt-probnp testing
|
EP4365598A1
(de)
|
2022-11-07 |
2024-05-08 |
Hôpitaux Universitaires Saint-Louis-Lariboisière |
Schnelle optimierung von oralen herzinsuffizienztherapien mithilfe von nt-probnp-tests
|